Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I - PubMed (original) (raw)
Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I
A Skottner et al. Endocrinology. 1989 May.
Abstract
A new mutant GH-deficient dwarf rat has been used to study the effects of iv infusions of human GH (hGH) and recombinant human insulin-like growth factor I (hIGF-I). This animal has only about 5% of normal pituitary GH content, low circulating GH levels, and no regular GH surges. The defect seems to be specific for GH. Infusions of hIGF-I at 180 micrograms/day for 9 days elevated serum IGF-I concentrations significantly over those in the saline-infused controls (713 +/- 20 ng/ml vs. 395 +/- 31 ng/ml); hGH infusions did not raise IGF-I levels significantly (435 +/- 20 ng/ml). Gel filtration of serum samples showed that the high-dose hIGF-I infusions increased free IGF concentrations, without apparently altering the pattern of IGF-I binding whereas hGH infusions increased the amount of high mol wt IGF-I binding protein. Neither IGF-I nor hGH infusions affected the small amounts of rat GH present in the dwarf rat pituitary glands. Continuous iv infusions of hGH (200 mU/day for 9 days) stimulated body wt gain (2.1 +/- 0.2 g/day) and bone growth (96 +/- 9 microns/day) significantly compared to saline-infused dwarf rats (1.2 +/- 0.3 g/day and 43 +/- 3 microns/day). Infusions of hIGF-I at 180 micrograms/day produced a body wt gain (2.1 +/- 0.5 g/day) similar to that seen in the hGH-infused group but a significantly smaller stimulation of bone growth (63 +/- 3 microns/day). Infusion of a 5-fold lower dose of hIGF-I (36 micrograms/day for 9 days) had no effect on body wt or bone growth. Food intake was unaffected by either hGH or hIGF-I infusions. The pattern of tissue growth was affected differentially by hGH and IGF-I infusions that produced the same overall body wt gain. hGH induced a relatively proportional growth in most of the organs studied, whereas hIGF-I infusion at 180 micrograms/day stimulated a disproportionately greater growth of the kidney, adrenals, and spleen. In some of the animals, tissues were extracted for RIA of IGF-I; the amounts of IGF-I in the liver were similar in control, hGH, or IGF-I-infused animals, whereas kidney and adrenals from IGF-I infused animals contained larger amounts of immunoreactive IGF-I than did those tissues from hGH-treated rats. Thus, both hGH and hIGF-I can promote growth in the mutant dwarf rat, but they differ both quantitatively and qualitatively in their pattern of actions.
Similar articles
- Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats.
Dubuis JM, Deal C, Tsagaroulis P, Clark RG, Van Vliet G. Dubuis JM, et al. Endocrinology. 1996 Jul;137(7):2799-806. doi: 10.1210/endo.137.7.8770900. Endocrinology. 1996. PMID: 8770900 - Growth promoting activity of IGF-I in the rat.
Robinson IC, Clark RG. Robinson IC, et al. Acta Paediatr Scand Suppl. 1988;347:93-103. Acta Paediatr Scand Suppl. 1988. PMID: 3075842 - The sensitivity of hepatic CYP2C gene expression to baseline growth hormone (GH) bioactivity in dwarf rats: effects of GH-binding protein in vivo.
Wells T, Mode A, Floby E, Robinson IC. Wells T, et al. Endocrinology. 1994 May;134(5):2135-41. doi: 10.1210/endo.134.5.8156914. Endocrinology. 1994. PMID: 8156914 - Growth promotion by insulin-like growth factor I in hypophysectomized and diabetic rats.
Zapf J. Zapf J. Mol Cell Endocrinol. 1998 May 25;140(1-2):143-9. doi: 10.1016/s0303-7207(98)00042-2. Mol Cell Endocrinol. 1998. PMID: 9722182 Review. - Growth retardation in Down syndrome in relation to insulin-like growth factors and growth hormone.
Annerén G, Gustavson KH, Sara VR, Tuvemo T. Annerén G, et al. Am J Med Genet Suppl. 1990;7:59-62. doi: 10.1002/ajmg.1320370710. Am J Med Genet Suppl. 1990. PMID: 1963538 Review.
Cited by
- Insulin-like growth factor-1 stimulation of lymphopoiesis.
Clark R, Strasser J, McCabe S, Robbins K, Jardieu P. Clark R, et al. J Clin Invest. 1993 Aug;92(2):540-8. doi: 10.1172/JCI116621. J Clin Invest. 1993. PMID: 8349796 Free PMC article. - Skeletal response of male mice to anabolic hormone therapy in the absence of the Igfals gene.
Kennedy OD, Sun H, Wu Y, Courtland HW, Williams GA, Cardoso L, Basta-Pljakic J, Schaffler MB, Yakar S. Kennedy OD, et al. Endocrinology. 2014 Mar;155(3):987-99. doi: 10.1210/en.2013-1819. Epub 2014 Jan 1. Endocrinology. 2014. PMID: 24424061 Free PMC article. - The episodic secretory pattern of growth hormone regulates liver carbonic anhydrase III. Studies in normal and mutant growth-hormone-deficient dwarf rats.
Jeffery S, Carter ND, Clark RG, Robinson IC. Jeffery S, et al. Biochem J. 1990 Feb 15;266(1):69-74. doi: 10.1042/bj2660069. Biochem J. 1990. PMID: 1968744 Free PMC article. - Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Effect on metabolic and hormonal patterns.
Goeters C, Mertes N, Tacke J, Bolder U, Kuhmann M, Lawin P, Löhlein D. Goeters C, et al. Ann Surg. 1995 Nov;222(5):646-53. doi: 10.1097/00000658-199511000-00007. Ann Surg. 1995. PMID: 7487212 Free PMC article. Clinical Trial. - Evidence for suppression of immune function by insulin-like growth factor-1 in dwarf rats in vivo.
Schurmann A, Spencer GS, Berry CJ, Decuypere E, Goddeeris B. Schurmann A, et al. Experientia. 1996 Jan 16;52(1):55-9. doi: 10.1007/BF01922416. Experientia. 1996. PMID: 8575560
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials